Point5 Stable Shareholder Returns

Point5 安定した株主還元Point5 安定した株主還元

ASKA Pharmaceutical Holdings regards the return of profits to shareholders as an important management issue and pays stable dividends. For FY2023, the Company paied a year-end dividend of 20 yen per share, which, together with the interim dividend of 20 yen per share already paid, resulted in an annual dividend of 40 yen per share.
For FY2024, the Company plans to pay an annual dividend of 50 yen per share (interim dividend: 25 yen per share, year-end dividend: 25 yen per share), which is higher than the previous fiscal year.
(As of June 26, 2024)


* Interim dividends 7 yen in FY2021 are derived from other capital surplus, and are excluded from dividend payout ratio

Changes in Net Income and Dividends

Profit attributable
to owners of
parent
(Millions of yen)
 Dividends per share (yen) Dividend
payout
ratio
lnterim Year-end Total
FY2024
(Forecast)		 5,000 25.00 25.00 50.00 28.3%
FY2023 7,545 20.00 20.00 40.00 15.0%
FY2022 4,238 8.00 8.00 16.00 10.7%
FY2021※1 4,290 7.00 8.00 15.00 5.3%
FY2020 2,713 7.00 7.00 14.00 14.6%
FY2019※2 649 7.00 10.00 17.00 74.0%
(Notes)
1. Interim dividend of 7 yen in FY2021 is derived from other capital surpluses and is excluded from the dividend payout ratio.
2. For the fiscal year ending March 31, 2020, we paid a commemorative dividend of 17 yen to celebrate the 100th anniversary of the Company's founding.